Thuja Capital Healthcare Seed Fund II invests in Nutrileads

Date: 18/11/2015

18 November 2015, Utrecht – Thuja Capital today announced that it has invested in Wageningen-based Nutrileads, a start-up company active in the field of medical and functional foods. Thuja acted as lead investor, heading a syndicate of Shift Invest, PPMOost and DSM Venturing. 

Nutrileads develops nutritional ingredients for application in health-promoting food products. The company was founded in December 2011 based on an invention initially made at Unilever. In 2013, NutriLeads, together with NIZO Food Research, obtained a grant from the topsector Agri &Food to start the preclinical development of its lead ingredient.

Nutrileads’ lead ingredient is derived from a traditional herbal remedy, which was shown in clinical trials to support immune function and to improve resistance to infections. It was discovered that the active component can be sustainably sourced from food crops. NutriLeads develops this proprietary ingredient as dietary supplement and for application in specialized functional and medical food products.

The full press release can be found here.